Old Web
English
Sign In
Acemap
>
authorDetail
>
Qingling Zhang
Qingling Zhang
Janssen Pharmaceutica
Hepatitis C virus
Prodrug
Odalasvir
Simeprevir
Pharmacokinetics
2
Papers
20
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Synthesis and Anti-HCV Activities of 4′-Fluoro-2′-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4′-Fluoro-2′-C-methyluridine 5′-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection
2019
Journal of Medicinal Chemistry
Guangyi Wang
Natalia B. Dyatkina
Marija Prhavc
Caroline Williams
Vladimir Serebryany
Yujian Hu
Yongfei Huang
Jinqiao Wan
Xiangyang Wu
Jerome Deval
Amy Fung
Zhinan Jin
Hua Tan
K. Shaw
Hyunsoon Kang
Qingling Zhang
Yuen Tam
Antitsa Dimitrova Stoycheva
Andreas Jekle
David Bernard Smith
Leonid Beigelman
Show All
Source
Cite
Save
Citations (16)
Pharmacokinetics, safety, and tolerability of the 2‐ and 3‐direct‐acting antiviral combination of AL‐335, odalasvir, and simeprevir in healthy subjects
2018
Pharmacology Research & Perspectives
Thomas N. Kakuda
Matthew W. McClure
Christopher Westland
Jennifer Vuong
Marie‐Claude Homery
Gwendoline Poizat
Laure Viguerie
Caroline Denot
Alain Patat
Qingling Zhang
James Hui
David Apelian
David Bernard Smith
Sushmita Chanda
John Fry
Show All
Source
Cite
Save
Citations (4)
1